Fair value (multi-method)
Four independent methods triangulate what ELV is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$582.46
Method range
$176.40 – $582.46
median $450.34
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $582.46 | +49.70% |
| Exit multiple | $460.50 | +18.35% |
| Analyst target | $440.17 | +13.13% |
| Graham number | $176.40 | -54.66% |
- Forward DCF$582.46
- Exit multiple$460.50
- Analyst target$440.17
- Graham number$176.40
Stock price
$389.09
FCF / share (TTM)
$7.46
3Y FCF CAGR
-16.5%
Fair value @ hist. growth
$33.72
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
16.0%
per year over your projection horizon
Margin of safety -1,053.9% vs hist-growth DCF
Historical 3Y CAGR
-16.5%
Your model implies
16.0%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -17% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.1% | 12.1% | 11.0% | 9.7% | 8.3% | 6.6% |
| 7.1% | 15.0% | 14.1% | 13.1% | 11.9% | 10.7% |
| 8.1% | 17.6% | 16.8% | 16.0% | 15.0% | 14.0% |
| 9.1% | 20.0% | 19.3% | 18.6% | 17.8% | 17.0% |
| 10.1% | 22.2% | 21.6% | 21.0% | 20.3% | 19.6% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net debt
$23.7B
Total debt − cash
Beta
0.68
Vs market benchmark
Frequently asked questions
Elevance Health (ELV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks3.21% TTM
- Dividend Profile1.76% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History1 split
How this company returns cash to shareholders — buybacks, dividends, and stock splits.